Patent · US Active

Substituted imidazo [1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives

US7671048B2 · kind B2 · utility

1Cited by

5References

18Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Henner Knust · Rheinfelden (Baden), DE
Heinz Stadler · Basel, CH
Andrew Thomas · Birsfelden, CH

Key dates

Filing date	Oct 7, 2005
Grant date	Mar 2, 2010
Priority date	—
Expiry date	Aug 27, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is concerned with a method of treating a disease selected from the group consisting of cognitive disorders, anxiety, Alzheimer's disease, and schizophrenia comprising administering a therapeutically effective amount of a substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives of the following formulawherein

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.